EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Molecular and serological evidence of chikungunya virus among dengue suspected patients in Sri Lanka

Mya Myat Ngwe Tun, Maurine Mumo Mutua, Shingo Inoue, Yuki Takamatsu, Satoshi Kaneko, Takeshi Urano, Rohitha Muthugala, Lakkumar Fernando, Menaka Hapugoda, Yins Gunawardene, Kouichi Morita

Journal of Infection and Public Health · 2025-05 · 18 (5) · 102709

DOI: 10.1016/j.jiph.2025.102709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2025-05. Verfasst von Mya Myat Ngwe Tun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan; Center for Vaccines …. Hauptthemen laut MEDLINE: Dengue, Chikungunya virus, Chikungunya Fever. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, International Atomic Energy Agency, National Science Foundation of Sri Lanka.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DengueChikungunya virusChikungunya FeverHumansSri LankaAntibodies, ViralAdultFemaleMaleAdolescentMiddle AgedImmunoglobulin MYoung AdultImmunoglobulin GAntibodies, NeutralizingPrevalenceChildDisease OutbreaksReal-Time Polymerase Chain ReactionSeroepidemiologic StudiesAgedChild, PreschoolDengue Virus

Stichwörter der Autor:innen

Chikungunya feverMolecular and serological detectionSri LankaSuspected dengue patients

Substanzen

Antibodies, ViralImmunoglobulin MImmunoglobulin GAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan; Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane U…
  • Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan; Graduate School of Health, Kenya Medical Research Institute, Nairobi, Kenya.
  • Kenya Research Station, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  • Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  • Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo 693-8501, Japan.
  • Department of Virology, National Hospital Kandy 20000, Sri Lanka.

Förderung

  • Japan Agency for Medical Research and Development
  • International Atomic Energy Agency
  • National Science Foundation of Sri Lanka
  • Heiwa Nakajima Foundation
  • Kurozumi Medical Foundation
  • Shimane University

Zitieren

APA

Ngwe Tun, M. M., Mutua, M. M., Inoue, S., Takamatsu, Y., Kaneko, S., Urano, T., Muthugala, R., Fernando, L., Hapugoda, M., Gunawardene, Y., & Morita, K. (2025). Molecular and serological evidence of chikungunya virus among dengue suspected patients in Sri Lanka. Journal of Infection and Public Health, 18(5), 102709. https://doi.org/10.1016/j.jiph.2025.102709

Vancouver

Ngwe Tun MM, Mutua MM, Inoue S, Takamatsu Y, Kaneko S, Urano T, et al. Molecular and serological evidence of chikungunya virus among dengue suspected patients in Sri Lanka. Journal of Infection and Public Health. 2025;18(5):102709. doi:10.1016/j.jiph.2025.102709

BibTeX
@article{NgweTun2025,
  author = {Ngwe Tun, Mya Myat and Mutua, Maurine Mumo and Inoue, Shingo and Takamatsu, Yuki and Kaneko, Satoshi and Urano, Takeshi and Muthugala, Rohitha and Fernando, Lakkumar and Hapugoda, Menaka and Gunawardene, Yins and Morita, Kouichi},
  title = {Molecular and serological evidence of chikungunya virus among dengue suspected patients in Sri Lanka},
  journal = {Journal of Infection and Public Health},
  year = {2025},
  volume = {18},
  number = {5},
  pages = {102709},
  doi = {10.1016/j.jiph.2025.102709}
}
Kostenlos starten →